GlassScriptPhysician profile
Victor Olujimi
NPI 1104069160
$16,531.16
in general payments reported to CMS, 2019-2025
7 companies · $5,937 in 2025
The $5,937 reported for 2025 was more than what 83% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $1,900 · 2021: $1,378 · 2022: $1,544 · 2023: $2,308 · 2024: $2,378 · 2025: $5,937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,750 · Travel and Lodging: $2,830 · Food and Beverage: $2,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,750.00 |
| Travel and Lodging | $2,830.02 |
| Food and Beverage | $2,043.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,468.79 | 2019-2025 | |
| Gotham Surgical Solutions & Devices, INC. | $3,452.83 | 2019-2021 | |
| Polaris Technology Solutions LLC | $976.84 | 2023-2025 | |
| Exactech, INC. | $306.31 | 2024-2025 | |
| Depuy Synthes Sales INC. | $138.24 | 2024 | Inhance |
| Heron Therapeutics, INC. | $108.15 | 2025 | Zynrelef |
| Gemini Mountain Medical, LLC | $80.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Olujimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.